Prolonged remission of advanced bronchoalveolar adenocarcinoma in a dog treated with autologous, tumour-derived chaperone-rich cell lysate (CRCL) vaccine

Only Missense Mutations Affecting the DNA Binding Domain of P53 Influence Outcomes in Patients with Breast Carcinoma

(2013) Frédérique Végran et al.   PLoS One

Medulloblastoma Exosome Proteomics Yield Functional Roles for Extracellular Vesicles

(2012) Laura M. Epple et al.   PLoS One

Discovery of Imidazoquinolines with Toll-Like Receptor 7/8 Independent Cytokine Induction

(2012) Ce Shi et al.   ACS Medicinal Chemistry Letters

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy

(2012) Erika Vacchelli et al.   OncoImmunology

TP53 Mutations in Canine Brain Tumors

(2011) D. York et al.   VETERINARY PATHOLOGY

Association of Blood Monocyte and Lymphocyte Count and Disease-Free Interval in Dogs with Osteosarcoma

(2010) J.L. Sottnik et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Evaluation of immunological status in tumor-bearing dogs

(2009) Hiroshi Itoh et al.   VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY

Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group

(2008) Alessandro Testori et al.   JOURNAL OF CLINICAL ONCOLOGY

Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression

(2008) N. Larmonier et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Impact of primary tumour stage on survival in dogs with solitary lung tumours

(2008) G. A. Polton et al.   JOURNAL OF SMALL ANIMAL PRACTICE

A chaperone protein-enriched tumor cell lysate vaccine generates protective humoral immunity in a mouse breast cancer model

(2008) G. Li et al.   MOLECULAR CANCER THERAPEUTICS

TP53 Gene Mutations in Canine Osteosarcoma

(2008) JOLLE KIRPENSTEIJN et al.   VETERINARY SURGERY